The ACRF Image X Institute is a centre for innovation in radiation therapy and cancer imaging technologies.
We create, share and apply scientific knowledge to improve health by building new technology for cancer imaging and targeted radiation therapy.
We engage with industry, hospitals, international collaborators and universities to forge relationships that help take our projects from lab bench to patient bedside.
Dr Paul Liu featured on Phyics World
Paul Liu, has been featured on the prominent Physics news website for his work: MRI-Linac enables simultaneous MLC tracking of two moving targets
Paul has described the use of an MRI-Linac to simultaneously track the motion of two treatment targets. “There are many radiotherapy cases that involve simultaneous treatment of multiple targets,” he said, citing examples such as locally advanced prostate or lung tumours, and oligometastases.
Study identifies missing piece needed for lower-cost, high-quality MRI
David Waddington‘s paper “High-sensitivity in vivo contrast for ultra-low field magnetic resonance imaging using superparamagnetic iron oxide nanoparticles” has been published in Science Advances. The research was completed during David’s Fulbright scholarship, in collaboration with friend of the institute, Zdenka Kuncic (University of Sydney) and Matt Rosen (Massachussetts General Hospital), among others. The paper has been featured in the university’s News and Opinion here, and Medical Xpress here.
$2.1M awarded by NHMRC.
Professor Paul Keall has been awarded a $2.1M investigator grant for the project Cancer Imaging and Targeted Radiation Therapy: From Discovery to Clinical Practice. This funding will allow us to advance real-time targeted radiotherapy by better imaging, targeting and adapting radiation therapy to moving tumours, and sparing surrounding healthy organs. It will also enable us to explore the delivery of personalised anatomically and physiologically targeted radiation therapy by tailoring treatments to individual patients.
Record Number of Early Career Fellowships awarded.
A trio of early career research fellows from the ACRF Image X Institute at the University of Sydney will begin cutting-edge research missions to improve cancer radiation therapy this year, thanks to support from Cancer Institute NSW and the NHMRC. Dr Brendan Whelan, Dr David Waddington and Dr Paul Liu will each be tackling unique challenges associated with the Australian MRI Linac, a powerful experimental cancer radiation therapy system based at Liverpool Hospital.
Learn about The Australian MRI Linac Program here.
Read more news here.
The ACRF Image X Institute is proudly supported by the Australian Cancer Research Foundation.